Blasco Oliete M, Torres Bouza C, Medina Bustillo B, Sanz Cuesta T, Neira León M
Médico de Familia. EAP Humanes. Area 9. IMSALUD. Madrid. España.
Aten Primaria. 2003 Feb 28;31(3):170-7. doi: 10.1016/s0212-6567(03)70678-7.
To assess primary care users' views on generic drugs, approach to them and degree of understanding of them; and to find the importance they attach to the economic cost of medication.
Transversal, descriptive study.
Primary care.
A sample of 231 patients was selected from all the people over 18 who attended the health centre for medical consultation during 2001.
60% (95% CI, 55.22%-67.42%) of those surveyed said they had heard of generic medicines. The communications media were the main source of information, accounting for 78.4% of cases (95% CI, 69.19%-83.96%). 48.04% (95% CI, 38.04%-58.16%) of those who had heard of generic medicines had taken them on some occasion; and 32.4% (95% CI, 23.42%-42.34%) normally took them. 76.47% (95% CI, 67.04%-84.30%) did not mind or, where appropriate, would not mind if their doctor changed a medicine they normally took for a generic one. The mean age of those who did not mind was significantly lower than that of those who did. 50% (95% CI, 42.25%-52.75%) of those questioned were very interested in the cost of drugs prescribed by their doctors: people still working were more interested than those on a pension. 67.6% (95% CI, 60.06%-74.61%) believed that doctors should try to prescribe the cheapest drugs, as long as they were equally efficacious. 78.8% of those questioned (95% CI, 71.91%-84.70%) would choose the cheaper of two drugs which were the same bar the cost.
Most patients in our study were aware of generic drugs and were not against the replacement of a medicine they were already taking by a generic one. They did not relate drugs' cost to their quality.
评估基层医疗服务使用者对非专利药的看法、对待非专利药的方式以及对其的了解程度；并了解他们对药物经济成本的重视程度。
横向描述性研究。
基层医疗服务机构。
从2001年到健康中心就医咨询的所有18岁以上人群中选取了231名患者作为样本。
60%（95%可信区间，55.22%-67.42%）的受访者表示听说过非专利药。传播媒体是主要信息来源，占78.4%（95%可信区间，69.19%-83.96%）的情况。48.04%（95%可信区间，38.04%-58.16%）听说过非专利药的人曾在某些情况下服用过；32.4%（95%可信区间，23.42%-42.34%）通常服用非专利药。76.47%（95%可信区间，67.04%-84.30%）不介意或者在适当情况下不介意医生将他们通常服用的药物换成非专利药。不介意的人的平均年龄显著低于介意的人。50%（95%可信区间，42.25%-52.75%）的受访者对医生开的药的费用非常感兴趣：仍在工作的人比领取养老金的人更感兴趣。67.6%（95%可信区间，60.06%-74.61%）认为医生应该尽量开最便宜的药，只要它们疗效相同。78.8%的受访者（95%可信区间，71.91%-84.70%）会在两种除价格外相同的药物中选择较便宜的那种。
我们研究中的大多数患者了解非专利药，并且不反对将他们正在服用的药物换成非专利药。他们不将药物的成本与质量联系起来。
